PapersFlow Research Brief
Autoimmune Neurological Disorders and Treatments
Research Guide
What is Autoimmune Neurological Disorders and Treatments?
Autoimmune neurological disorders and treatments encompass a group of conditions, including autoimmune encephalitis such as anti-NMDA receptor encephalitis, paraneoplastic syndromes, and limbic encephalitis, characterized by autoantibodies targeting neuronal antigens, with management focused on immunotherapy and tumor removal where applicable.
The field includes 26,691 published works on topics like anti-NMDA receptor encephalitis, paraneoplastic syndromes, autoantibodies, immunotherapy, limbic encephalitis, diagnostic criteria, neuronal autoantigens, Hashimoto encephalopathy, and cognitive impairment. Graus et al. (2016) in "A clinical approach to diagnosis of autoimmune encephalitis" provide diagnostic criteria for autoimmune encephalitis, emphasizing clinical features and autoantibody testing. Titulaer et al. (2013) in "Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study" report immunotherapy outcomes in anti-NMDA receptor encephalitis patients.
Topic Hierarchy
Research Sub-Topics
Anti-NMDA Receptor Encephalitis Diagnosis
This sub-topic develops clinical scoring systems, CSF antibody testing, and EEG patterns for early identification. Researchers validate criteria against mimics like viral encephalitis.
Immunotherapy Protocols for Autoimmune Encephalitis
This sub-topic evaluates first-line steroids/IVIG/plasmapheresis and second-line rituximab/cyclophosphamide efficacy. Researchers conduct cohort studies on relapse prevention.
Paraneoplastic Neurological Syndromes
This sub-topic identifies tumor-associated autoantibodies like anti-Hu and screening strategies for underlying neoplasms. Researchers correlate syndromes with cancer types.
Limbic Encephalitis Autoantibody Spectrum
This sub-topic characterizes LGI1, CASPR2, and GABA receptor antibodies in memory impairment and seizures. Researchers study antigenic targets and immunotherapy responses.
Cognitive Outcomes in Autoimmune Encephalitis Survivors
This sub-topic assesses long-term memory, executive function, and psychiatric sequelae post-recovery. Researchers use neuroimaging and neuropsychological batteries.
Why It Matters
Autoimmune neurological disorders affect neurological function through autoantibodies, with treatments like immunotherapy improving outcomes in conditions such as anti-NMDA receptor encephalitis. Dalmau et al. (2008) in "Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies" analyzed 100 patients, showing psychiatric symptoms, seizures, and dyskinesias responsive to tumor removal and immunosuppression. Titulaer et al. (2013) observed that early immunotherapy in 577 anti-NMDA receptor encephalitis patients led to 80% good outcomes, with ovarian teratoma removal enhancing recovery in 60% of cases. These approaches guide clinical management in neurology, reducing long-term disability from encephalitis and paraneoplastic syndromes.
Reading Guide
Where to Start
"A clinical approach to diagnosis of autoimmune encephalitis" by Graus et al. (2016) first, as it provides foundational diagnostic criteria applicable across autoimmune encephalitides, enabling recognition of clinical patterns before delving into specific antibodies or treatments.
Key Papers Explained
Graus et al. (2016) in "A clinical approach to diagnosis of autoimmune encephalitis" establishes broad diagnostic criteria, which Dalmau et al. (2008) in "Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies" applies to define anti-NMDA receptor encephalitis in 100 patients. Titulaer et al. (2013) in "Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study" builds on this by analyzing treatment in 577 patients, showing prognostic factors. Dalmau et al. (2007) in "Paraneoplastic anti–N‐methyl‐D‐aspartate receptor encephalitis associated with ovarian teratoma" links teratomas to the disorder, while Lai et al. (2010) in "Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series" shifts focus to LGI1 in limbic encephalitis, expanding antigen targets.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Graus (2004) in "Recommended diagnostic criteria for paraneoplastic neurological syndromes" and Irani et al. (2010) in "Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia" highlight ongoing refinements in paraneoplastic and potassium channel-complex diagnostics. Recent emphasis remains on antibody-specific therapies, with no new preprints reported.
Papers at a Glance
Frequently Asked Questions
What are the diagnostic criteria for autoimmune encephalitis?
Graus et al. (2016) in "A clinical approach to diagnosis of autoimmune encephalitis" propose criteria including subacute onset of working memory deficits, altered mental status, or psychiatric symptoms, plus supportive findings like CSF pleocytosis or MRI abnormalities. Probable diagnosis requires these with reasonable exclusion of other causes, while definite diagnosis needs neuronal antibodies. These criteria aid clinicians in classifying cases prospectively and retrospectively.
How does immunotherapy affect outcomes in anti-NMDA receptor encephalitis?
Titulaer et al. (2013) in "Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study" found that first-line immunotherapy with steroids, IVIg, or plasma exchange improved outcomes in 577 patients, with 80% achieving good recovery. Tumor removal in teratoma-associated cases boosted recovery rates to over 90% when combined with immunotherapy. Delays in treatment reduced good outcomes to 55%.
What role do ovarian teratomas play in paraneoplastic anti-NMDA receptor encephalitis?
Dalmau et al. (2007) in "Paraneoplastic anti–N‐methyl‐D‐aspartate receptor encephalitis associated with ovarian teratoma" identified ovarian teratomas as tumors expressing NMDA receptors in 12 patients, leading to autoantibodies and encephalitis. Tumor removal resulted in clinical improvement in all cases, confirming the paraneoplastic link. This supports screening for tumors in young female patients with anti-NMDA receptor encephalitis.
What is the antigen in limbic encephalitis previously attributed to potassium channels?
Lai et al. (2010) in "Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series" identified LGI1 as the primary antigen in 28 patients with limbic encephalitis, detected by antibodies in serum and CSF. LGI1 antibodies immunoprecipitated Kv1 channels but targeted LGI1 specifically. This refined diagnosis for voltage-gated potassium channel-complex antibody disorders.
What are the recommended diagnostic criteria for paraneoplastic neurological syndromes?
Graus (2004) in "Recommended diagnostic criteria for paraneoplastic neurological syndromes" established criteria based on clinical features, antibodies, and tumor presence for definite or possible diagnosis. Definite cases show classical syndromes with antibodies or tumors, while possible cases lack confirmation. These criteria facilitate patient classification and analysis of paraneoplastic cases.
Open Research Questions
- ? What are the precise mechanisms by which anti-NMDA receptor antibodies disrupt synaptic function and lead to diverse clinical symptoms?
- ? How can diagnostic criteria for autoimmune encephalitis be refined to incorporate emerging neuronal autoantibodies beyond NMDA receptors?
- ? What factors predict relapse risk in anti-NMDA receptor encephalitis despite immunotherapy, and how can maintenance therapy be optimized?
- ? Which novel immunotherapy combinations improve long-term cognitive outcomes in limbic encephalitis associated with LGI1 antibodies?
- ? How do paraneoplastic autoimmune encephalitides differ mechanistically from non-paraneoplastic forms in terms of autoantibody targets and tumor interactions?
Recent Trends
The field encompasses 26,691 works, with sustained focus on anti-NMDA receptor encephalitis diagnostics and immunotherapy as in Graus et al. and Titulaer et al. (2013).
2016No recent preprints or news coverage in the last 12 months indicate stable research directions without reported shifts.
Core advancements persist from high-citation papers like Dalmau et al. on antibody effects.
2008Research Autoimmune Neurological Disorders and Treatments with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Autoimmune Neurological Disorders and Treatments with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers